Phaserx Stock Fundamentals
PhaseRx fundamentals help investors to digest information that contributes to PhaseRx's financial success or failures. It also enables traders to predict the movement of PhaseRx Stock. The fundamental analysis module provides a way to measure PhaseRx's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to PhaseRx stock.
PhaseRx |
PhaseRx Company Return On Equity Analysis
PhaseRx's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current PhaseRx Return On Equity | -228.17 |
Most of PhaseRx's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, PhaseRx is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, PhaseRx has a Return On Equity of -228.17. This is much higher than that of the Healthcare sector and notably higher than that of the Biotechnology industry. The return on equity for all United States stocks is notably higher than that of the company.
PhaseRx Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining PhaseRx's current stock value. Our valuation model uses many indicators to compare PhaseRx value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across PhaseRx competition to find correlations between indicators driving PhaseRx's intrinsic value. More Info.PhaseRx is considered to be number one stock in return on equity category among related companies. It is considered to be number one stock in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value PhaseRx by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for PhaseRx's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the PhaseRx's earnings, one of the primary drivers of an investment's value.PhaseRx Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses PhaseRx's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of PhaseRx could also be used in its relative valuation, which is a method of valuing PhaseRx by comparing valuation metrics of similar companies.PhaseRx is currently under evaluation in return on equity category among related companies.
PhaseRx Fundamentals
| Return On Equity | -228.17 | |||
| Return On Asset | -64.2 | |||
| Current Valuation | 3.46 M | |||
| Shares Outstanding | 11.69 M | |||
| Shares Owned By Insiders | 11.22 % | |||
| Shares Owned By Institutions | 51.52 % | |||
| Number Of Shares Shorted | 8.39 K | |||
| Price To Earning | (0.79) X | |||
| Price To Book | 5.65 X | |||
| EBITDA | (12.96 M) | |||
| Net Income | (13.89 M) | |||
| Cash And Equivalents | 5.26 M | |||
| Cash Per Share | 0.45 X | |||
| Total Debt | 5.44 M | |||
| Debt To Equity | 264.10 % | |||
| Current Ratio | 2.14 X | |||
| Book Value Per Share | (0.03) X | |||
| Cash Flow From Operations | (12.82 M) | |||
| Short Ratio | 0.05 X | |||
| Earnings Per Share | (1.19) X | |||
| Number Of Employees | 10 | |||
| Market Capitalization | 3.28 M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards PhaseRx in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, PhaseRx's short interest history, or implied volatility extrapolated from PhaseRx options trading.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as PhaseRx using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Consideration for investing in PhaseRx Stock
If you are still planning to invest in PhaseRx check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PhaseRx's history and understand the potential risks before investing.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |